ARTICLE | Clinical News
Cytolin: AMUN started a U.S. dose-escalating Phase Ib trial of Cytolin in 13 HIV patients.
January 22, 2002 8:00 AM UTC
Amerimmune Pharmaceuticals Inc. (AMUN), Woodland Hills, Calif. Product: Cytolin Business: Infectious diseases Therapeutic category: Antibody, Immune modulation Target: Adhesion molecules on immune ce...